S9788, AN EFFECTIVE NEW COMPOUND FOR P-GLYCOPROTEIN-MULTIDRUG RESISTANCE (PGP-MDR1) MODULATION IN NON-HODGKINS-LYMPHOMA (NHL) WHEN ASSOCIATED TO DOXORUBICIN (DOX) - PRELIMINAR RESULTS OF BIOLOGIC ASSAYS AND PHASE-I-II STUDY

Authors
ROSSI JF PASCAL P PINGUET F FABBRO M LEGOUFFE E BERGER E GIROUX B
Citation
Jf. Rossi et al., S9788, AN EFFECTIVE NEW COMPOUND FOR P-GLYCOPROTEIN-MULTIDRUG RESISTANCE (PGP-MDR1) MODULATION IN NON-HODGKINS-LYMPHOMA (NHL) WHEN ASSOCIATED TO DOXORUBICIN (DOX) - PRELIMINAR RESULTS OF BIOLOGIC ASSAYS AND PHASE-I-II STUDY, Blood, 84(10), 1994, pp. 10000647-10000647
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000647 - 10000647
Database
ISI
SICI code
0006-4971(1994)84:10<10000647:SAENCF>2.0.ZU;2-V